Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. St. Jude Medical touts 1st U.S. commercial implantations for Quadra Assura with MultiPoint pacing
St. Jude Medical today touted the 1st U.S. commercial implantations for its Quadra Assura MP cardiac resynchronization therapy defibrillator, featuring its MultiPoint pacing technology.
The MultiPoint tech is the 1st to hit the U.S. market that allows physicians to tailor pacing therapy by controlling multiple pulses to the left ventricle for each heartbeat. Each lead in the system can deliver 2 pulses per heartbeat, St. Jude said. Read more
4. Material in Medtronic’s cardiac leads makes the Space Technology Hall of Fame
Medtronic said today that lead material used in its cardiac leads, NASA Langley Research Center-Soluble Imide, was inducted into the Space Technology Hall of Fame.
The induction ceremony took place at the Space Foundation’s 32nd Space Symposium in Colorado Springs, Colo. Read more
3. Proteus Digital Health lands $50m Series H round
Proteus Digital Health last week said that it raised a $50 million Series H equity round it plans to use to expand the footprint of its Discover “smart pill.”
The device uses an ingestible sensor, the size of a grain of sand, which is activated when it reaches the stomach and communicates with a wearable sensor patch which records time of ingestion and personalized data such as heart rate, physical activity and rest. The data can be seen by a patient through a mobile app, which can be shared with healthcare professionals to optimize patient treatment. Read more
2. China’s Venus Medtech buys Transcatheter Technologies
Transcatheter Technologies said today that it agreed to an acquisition by Chinese replacement heart valve maker Venus Medtech for an undisclosed amount.
Regensburg, Germany-based Transcatheter Technologies makes the Trinity transcatheter aortic valve replacement, which it touts as the only TAVR device that’s “truly” repositionable, even after full implantation. Trinity is also designed to minimize or eliminate the paravalvular leakage that’s plagued early TAVR devices, the company has said. Read more
1. FDA approves new leads for Nevro’s Senza spinal cord stimulator
Nevro Corp. said it won pre-market approval from the FDA for new surgical leads designed to be used with its Senza spinal cord stimulation device.
The Senza device, which won an FDA nod in May 2015, is designed to deliver high-frequency electrical impulses of up to 10,000Hz to the spinal cord to avoid the tingling sensation known as paresthesia that bothers some SCS patients. The FDA approval allows Redwood City, Calif.-based Nevro to label the device’s HF10 therapy \ as superior to conventional spinal cord stimulators. Read more
The post MassDevice.com +5 | The top 5 medtech stories for April 18, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1MDQqi5
Cap comentari:
Publica un comentari a l'entrada